A Phase 1, Open-Label, Parallel Group Study to Evaluate

See also
Status	Clinical Trial	Phase
Completed	`NCT04210583` - RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity	N/A
Completed	`NCT03725410` - Multi-polar RF and PEMF for Treatment of Symptoms Associated With Vulvovaginal Atrophy	N/A
Recruiting	`NCT03823560` - Performance and Safety of Class IIb MD Celegyn® in VVA	N/A
Completed	`NCT02253173` - Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women	Phase 3
Withdrawn	`NCT03666819` - Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy	Phase 2
Recruiting	`NCT04746456` - Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM
Completed	`NCT04607798` - Multi-polar RF and PEMF for Treatment of Vulvovaginal Atrophy	N/A
Completed	`NCT04766957` - Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy	N/A
Completed	`NCT01455597` - Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)	Phase 3
Completed	`NCT03557398` - Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women	N/A
Completed	`NCT03044652` - Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol	Phase 4
Completed	`NCT03536585` - Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity	N/A
Completed	`NCT04629885` - Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms	Phase 2
Recruiting	`NCT04579991` - Effects of Visnadin, Ethyl Ximeninate, Coleus Barbatus and Millet in Emulgel on Sexual Function in Postmenopausal Women	N/A
Recruiting	`NCT05562518` - GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.	Phase 4
Completed	`NCT02419729` - Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy	Phase 3
Completed	`NCT02085980` - Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy	N/A
Completed	`NCT01319968` - Postpartum Dyspareunia Resulting From Vaginal Atrophy	N/A
Recruiting	`NCT03782480` - Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy	Phase 3
Completed	`NCT04887701` - Non-hormonal Medical Device for Treatment of Vulvovaginal Atrophy (VVA) in Post-Menopausal Women	N/A

NCT number	NCT05418426
Study type	Interventional
Source	Daré Bioscience, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	August 18, 2020
Completion date	January 27, 2022

A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms